Physician profile
Omar H Akhtar
NPI 1417150202
$532,990.05
in general payments reported to CMS, 2019-2025
5 companies · $81K in 2025
The $81K reported for 2025 was more than what 91% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $60K · 2021: $102K · 2022: $81K · 2023: $52K · 2024: $114K · 2025: $81K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $204K · Travel and Lodging: $40K · Food and Beverage: $2,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $203,625.00 |
| Travel and Lodging | $40,338.72 |
| Food and Beverage | $2,793.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $532,910.21 | 2019-2025 | Mako, Aequalis, Insignia |
| Depuy Synthes Sales INC. | $27.15 | 2025 | Orthovisc, Monovisc |
| Encore Medical, Lp | $21.30 | 2023 | Djo Surgical |
| Boston Scientific Corporation | $17.54 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $13.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Akhtar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.